Company intelligence / Profile preview

Cognita Labs

Santa Ana, California, United Statescognitalabs.com ↗

Ownership: Private
Employees: ~6
Development stage: Commercial

Overview

Cognita Labs has developed and commercialized several FDA-cleared digital medical devices for pulmonary care, including PulmoScan, CapMedic, and UltraSpiro. These products are designed to simplify lung function testing and inhaler use monitoring for asthma and COPD patients. The company’s solutions enable screening, diagnosis, remote monitoring, and data-driven management of chronic respiratory diseases in both clinical settings and at home.

Therapeutic areas: Pulmonology
Modalities: DeviceDigital health solutionNon-pharmacological therapy (coaching, monitoring)
Industry: Physiological Monitoring

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Cognita Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cognita Labs.

Explore the full profile